EN HU

Uray Iván Péter

Uray Iván Péter

Publication list

Uploaded publications:
44
Publications in DEA:
41
OA:
18
Date range:
1995-2025
2025
1.
Lengyel, M., Molnár, Á., Nagy, T., Jdeed, S., Garai, I., Horváth, Z., Uray, I. P.: Zymogen granule protein 16B (ZG16B) is a druggable epigenetic target to modulate the mammary extracellular matrix.
Cancer Sci. 116 (1), 81-94, 2025.
Journal metrics:
Q2 Cancer Research (2024)
D1 Medicine (miscellaneous) (2024)
Q1 Oncology (2024)
2023
2.
Jambrovics, K., Póliska, S., Scholtz, B., Uray, I. P., Balajthy, Z.: ATO Increases ROS Production and Apoptosis of Cells by Enhancing Calpain-Mediated Degradation of the Cancer Survival Protein TG2.
Int. J. Mol. Sci. 24 (13), 1-11, (article identifier: 10938), 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
3.
Kola, J. B., Turarova, B., Csige, D., Sipos, Á., Varga, L., Gergely, B., Refai, F. A., Uray, I. P., Docsa, T., Uray, K.: Stretch-Induced Down-Regulation of HCN2 Suppresses Contractile Activity.
Molecules. 28 (11), 1-14, (article identifier: 4359), 2023.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
4.
Jambrovics, K., Botó, P., Pap, A., Sarang, Z., Kolostyák, Z., Czimmerer, Z., Szatmári, I., Fésüs, L., Uray, I. P., Balajthy, Z.: Transglutaminase 2 associated with PI3K and PTEN in a membrane-bound signalosome platform blunts cell death.
Cell Death Dis. 14 (3), 1-10, (article identifier: 217), 2023.
Journal metrics:
Q1 Cancer Research
Q1 Cell Biology
Q1 Cellular and Molecular Neuroscience
Q1 Immunology
D1 Medicine (miscellaneous)
2022
5.
Jdeed, S., Lengyel, M., Uray, I. P.: Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal Breast Cells through TGF-[béta] Signaling.
Cells. 11 (17), 1-15, (article identifier: 2633), 2022.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
6.
Jdeed, S., Erdős, E., Bálint, B. L., Uray, I. P.: The Role of ARID1A in the Nonestrogenic Modulation of IGF-1 Signaling.
Mol. Cancer Res. 20 (7), 1071-1082, 2022.
Journal metrics:
Q1 Cancer Research
Q1 Molecular Biology
Q1 Oncology
2021
7.
Uray, I. P., Uray, K.: Mechanotransduction at the Plasma Membrane-Cytoskeleton Interface.
Int. J. Mol. Sci. 22 (21), 1-23, 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2020
8.
Szivos, L., Virga, J., Hortobágyi, T., Zahuczky, G., Uray, I. P., Jenei, A., Bognár, L., Árkosy, P., Klekner, Á.: Az inváziós spektrum prognosztikai jelentősége glioblastomában.
Ideggyogy. Szle. 73 (9-10), 317-325, 2020.
Journal metrics:
Q4 Neurology
Q4 Neurology (clinical)
9.
Jambrovics, K., Uray, I. P., Keillor, J. W., Fésüs, L., Balajthy, Z.: Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2.
Cancers (Basel). 12 (3), 648-, 2020.
Journal metrics:
Q2 Cancer Research
Q1 Oncology
2019
10.
Kocsis, J., Szekanecz, É., Bassam, A., Uhlyarik, A., Pápai, Z., Rubovszky, G., Mezősi, E., Rucz, K., Garai, I., Nagy, E. V., Uray, I. P., Horváth, Z.: First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: efficacy and Safety Analysis.
Exp. Clin. Endocrinol. Diabetes. 127 (4), 240-246, 2019.
Journal metrics:
Q3 Endocrinology
Q3 Endocrinology, Diabetes and Metabolism
Q2 Internal Medicine
Q2 Medicine (miscellaneous)
11.
Jambrovics, K., Uray, I. P., Keresztessy, Z., Keillor, J. W., Fésüs, L., Balajthy, Z.: Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-kB activation.
Haematol-Hematol. J. 104 (3), 505-515, 2019.
Journal metrics:
D1 Hematology
2018
12.
Chowdhury, P., Powell, R. T., Stephan, C., Uray, I. P., Talley, T., Karki, M., Tripathi, D. N., Park, Y. S., Mancini, M. A., Davies, P. J. A., Dere, R.: Bexarotene: a Novel Modulator of AURKA and the Primary Cilium in VHL-deficient Cells.
J. Cell Sci. 131, 1-12, 2018.
Journal metrics:
Q1 Cell Biology
2017
13.
Zhang, L., Shen, J., Yin, Y., Peng, Y., Wang, L., Hsieh, H. J., Shen, Q., Brown, P. H., Tao, K., Uray, I. P., Peng, G.: Identifying cell cycle modulators that selectively target aridia deficiency using high-throughput image-based screening.
SLAS Discovery. 1 (1), 1-14, 2017.
14.
Zhang, L., Peng, Y., Uray, I. P., Shen, J., Wang, L., Peng, X., Brown, P. H., Tu, W., Peng, G.: Natural product [béta]-thujaplicin inhibits homologous recombination repair and sensitizes cancer cells to radiation therapy.
DNA Repair. 60, 89-101, 2017.
Journal metrics:
D1 Biochemistry
Q1 Cell Biology
Q1 Molecular Biology
2016
15.
Uray, I. P., Dmitrovsky, E., Brown, P. H.: Retinoids and Rexinoids in Cancer Prevention: From Laboratory to Clinic.
Semin. Oncol. 43 (1), 49-64, 2016.
Journal metrics:
Q1 Hematology
Q1 Oncology
16.
Shepherd, J. H., Uray, I. P., Mazumdar, A., Tsimelzon, A., Savage, M., Hilsenbeck, S. G., Brown, P. H.: The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
Oncotarget. 7 (11), 1-16, 2016.
Journal metrics:
Q1 Oncology
2015
17.
Uray, I. P., Rodenberg, J. M., Zhang, Y., Hill, J. L., Brown, P. H.: Abstract 2804: The thiazolidinedione pioglitazone enhances the cancer preventive activity of the rexinoid LG100268 in Her2/neu induced breast cancer.
Cancer Res. 75 (15), 2804, 2015.
18.
Shen, J., Peng, Y., Wei, L., Zhang, W., Yang, L., Lan, L., Kapoor, P., Ju, Z., Mo, Q., Shih, I. M., Uray, I. P., Wu, X., Brown, P. H., Shen, X., Mills, G. B., Peng, G.: ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.
Cancer Discov. 5 (7), 752-767, 2015.
Journal metrics:
D1 Oncology
2014
19.
Batra, N., Speers, C., Uray, I. P., Mazumdar, A., Tsimelzon, A., Hilsenbeck, S. G., Mills, G. B., Brown, P. H.: Abstract 3299: Maternal embryonic leucine zipper kinase is critical for the growth and migration of triple negative breast cancer cells.
Cancer Res. 74 (19), 3299-3299, 2014.
20.
Xiong, A., Chen, H., Yang, Z., Cai, G., Wang, L., Ding, C., Xu, G. G., Wild, C., Ye, N., Uray, I. P., Zhou, J., Shen, Q.: Abstract 3805: Anticancer agent HJC0416 inhibits the growth of breast cancer xenografts via downregulating STAT3 signaling.
Cancer Res. 74 (19), 3805-3805, 2014.
21.
Sárvári, A. K., Veréb, Z., Uray, I. P., Fésüs, L., Balajthy, Z.: Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro.
Biochem. Biophys. Res. Commun. 450 (4), 1383-1389, 2014.
Journal metrics:
Q2 Biochemistry
Q1 Biophysics
Q3 Cell Biology
Q2 Molecular Biology
2012
22.
Hartman, Z. C., Tsimelzon, A., Uray, I. P., Hill, J. L., Zhang, Y., Mazumdar, A., Hilsenbeck, S. G., Chang, J., Mills, G. B., Brown, P. H.: Abstract 4862: Autocrine secreted IL-6 and IL-8 play critical and non-redundant roles in basal-like breast cancer cell transformation and growth in vitro and in vivo.
Cancer Res. 72 (8), 4862-4862, 2012.
23.
Wang, C., Uray, I. P., Mazumdar, A., Mayer, J. A., Brown, P. H.: SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
Breast Cancer Res. Treat. 134 (1), 101-115, 2012.
Journal metrics:
Q1 Cancer Research
Q1 Oncology
2011
24.
Uray, I. P., Rodenberg, J. M., Bissonnette, R. P., Brown, P. H., Mancini, M. A.: Cancer-Preventive Rexinoid Modulates Neutral Lipid Contents of Mammary Epithelial Cells through a Peroxisome Proliferator-Activated Receptor [gamma]-Dependent Mechanism.
Molecular Pharmacology. 81 (2), 228-238, 2011.
Journal metrics:
D1 Molecular Medicine
D1 Pharmacology
25.
Uray, I. P., Brown, P. H.: Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
Recent Results Cancer Res. 188, 147-162, 2011.
Journal metrics:
Q3 Cancer Research
Q1 Medicine (miscellaneous)
Q2 Oncology
DEENK University of Debrecen
© 2012 University of Debrecen